Biok gets pass in GMP renewal audit for Tiamulin Hydrogen Fumarate

On April 23 of 2010, Biok is audited by Ministry of Agriculture for GMP renewal on Tiamulin Hydrogen Fumarate (hereinafter referred to as Tiamulin). The result is good & Biok GMP operation is highly praised by audit team.

Tiamulin is a semisynthetic pleuromutilin antibiotic drug that is applied in veterinary medicine particularly for swine and poultry. As one of the leading manufacturers in China, since 2005, Biok has been GMP certified. Afterwards, Biok optimizes the production technique which improves much on quality and efficiency.

Biok will keep its efforts on technical innovation and strong supplying Tiamulin for global market.